- 恒指
- 25,757
- +436
- 大市成交 2,928億
- 即時維昇藥業－Ｂ
- 32.060-0.260 (-0.804%)
- 27/06/2025
- 盧安邦
- 1102(L)
- +435,000(L)
- 5,435,000(L)
- 4.77
- 24/04/2025
- 盧安邦
- 1312(S)
- 1,707,700(S)
- 5,000,000(L)
- 4.39
- 21/03/2025
- Vivo Plenilune IX Limited
- 1711(L)
- 37,167,064(L)
- 37,167,064(L)
- 32.62
- 21/03/2025
- Vivo Plenilune IX Limited
- 1001(L)
- 36,136,364(L)
- 36,136,364(L)
- 32.14
- 21/03/2025
- Vivo Capital Fund IX(Cayman), L.P.
- 1001(L)
- 36,136,364(L)
- 36,136,364(L)
- 32.14
- 21/03/2025
- Ascendis Pharma Endocrinology Division A/S
- 1701(L)
- 20,568,182(L)
- 18.05
- 21/03/2025
- Ascendis Pharma Bone Diseases A/S
- 1701(L)
- 12,855,114(L)
- 11.28
- 21/03/2025
- Ascendis Pharma A/S
- 1701(L)
- 41,136,364(L)
- 36.11
- 21/03/2025
- 盧安邦
- 1701(L)
1313(S)
- 5,000,000(L)
1,707,700(S)
- 5,000,000(L)
1,707,700(S)
- 4.39
1.49
- 21/03/2025
- Ascendis Pharma Growth Disorders A/S
- 1701(L)
- 7,713,068(L)
- 6.77
- 21/03/2025
- Vivo Capital IX (Cayman), LLC
- 1001(L)
- 36,136,364(L)
- 36,136,364(L)
- 32.14
- 21/03/2025
- Vivo Capital Fund IX(Cayman), L.P.
- 1711(L)
- 37,167,064(L)
- 37,167,064(L)
- 32.62
- 21/03/2025
- Vivo Capital IX (Cayman), LLC
- 1711(L)
- 37,167,064(L)
- 37,167,064(L)
- 32.62